Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Multikine plus standard of care versus standard of care alone in advanced oral cavity or soft palate squamous cell carcinoma
2010-019952-35Phase 3Completed
- Sponsor
- CEL-SCI Corporation
- Start
- Jul 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Oral Mucosal Carcinoma and squamous cell carcinoma of the soft palate comparing Multikine plus standard of care with Standard of care alone (2 arms). Primary endpoint: Overall survival. Started Jul 2010; status: completed.
02
Drugs
leukocyte interleukin
03
Conditions
Oral Mucosal Carcinomasquamous cell carcinoma of the soft palate
Beyond the preview
Go deeper on 2010-019952-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019952-35.